This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Mula, M. Articles by Schmitz, B. Social Bookmarking                         What's this?

Review: Depression in epilepsy: mechanisms and therapeutic approach

Department of Neurology, Amedeo Avogadro University, Novara, Italy

Bettina Schmitz

Department of Neurology, Vivantes Humboldt-Klinikum, Germany, bettina.schmitz@ vivantes.de

In patients with epilepsy, mood disorders represent a frequent psychiatric comorbidity but they often remain unrecognized and untreated. However, comorbid depression may have a major impact on the quality of life of patients with epilepsy, sometimes even more than the seizures. Among the potential neurobiological and psychosocial determinants, epilepsy-related variables (age at onset of seizures, temporal lobe epilepsy and frequency of seizures) and the antiepileptic drug treatment have been associated with depression. Nonetheless, data on treatment strategies are still limited with a lack of controlled trials on the use of antidepressant drugs. Moreover, the issue of psychotropic drug treatment of depression in epilepsy is interlinked with that of worsening seizures. This paper is aimed at discussing all these subjects in the light of current literature on the neurobiology of depression in epilepsy.

Key Words: epilepsy • depression • antiepileptic drugs • antidepressant drugs

Therapeutic Advances in Neurological Disorders, Vol. 2, No. 5, 337-344 (2009)
DOI: 10.1177/1756285609337340


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?